Difficulty: Medium
Average Score: 73%
Practice
Petit mal epilepsy is treated by
Correct answer
B
Rationale
In the treatment of petit mal epilepsy, ethosuximide (Option B) is the preferred drug due to its specific mechanism of action. Ethosuximide works by blocking T-type calcium channels in the thalamus, which are thought to be involved in the generation of absence seizures characteristic of petit mal epilepsy. This targeted mechanism makes ethosuximide more effective in controlling petit mal seizures compared to other antiepileptic drugs.
Phenobarbitone (Option A) is a barbiturate that is more commonly used for generalized tonic-clonic and complex partial seizures, not for petit mal epilepsy. Diazepam (Option C) is a benzodiazepine used for acute management of seizures or status epilepticus but is not a first-line treatment for petit mal epilepsy. Phenytoin (Option D) is more commonly used for tonic-clonic seizures and focal (partial) seizures, not petit mal epilepsy.
Educationally, understanding the specific mechanisms of action of different antiepileptic drugs is crucial for selecting the most appropriate treatment for specific seizure types. This knowledge helps healthcare professionals make informed decisions when managing patients with epilepsy to ensure optimal seizure control and minimize adverse effects. By grasping the pharmacology of CNS drugs, healthcare providers can tailor treatment regimens to individual patients and improve outcomes in epilepsy management.
Phenobarbitone (Option A) is a barbiturate that is more commonly used for generalized tonic-clonic and complex partial seizures, not for petit mal epilepsy. Diazepam (Option C) is a benzodiazepine used for acute management of seizures or status epilepticus but is not a first-line treatment for petit mal epilepsy. Phenytoin (Option D) is more commonly used for tonic-clonic seizures and focal (partial) seizures, not petit mal epilepsy.
Educationally, understanding the specific mechanisms of action of different antiepileptic drugs is crucial for selecting the most appropriate treatment for specific seizure types. This knowledge helps healthcare professionals make informed decisions when managing patients with epilepsy to ensure optimal seizure control and minimize adverse effects. By grasping the pharmacology of CNS drugs, healthcare providers can tailor treatment regimens to individual patients and improve outcomes in epilepsy management.